Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury
Related Experiment Video
Updated: Aug 14, 2026
A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia
Published on: May 12, 2026
Andrea M Vincent1, Martin J Stevens, Carey Backus
1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. andreav@umich.edu
Abstract:
The concept that oxidative stress is a key mediator of nerve injury in diabetes has led us to design therapies that target oxidative stress mechanisms. Using an in vitro model of glucose-treated dorsal root ganglion (DRG) neurons in culture, we can examine both free radical generation, using fluorimetric probes for reactive oxygen species, and cell death via the TUNEL assay. The cell culture system is scaled down to a 96-well plate format, and so is well suited to high-throughput screening. In the present study, we test the ability of three drugs, nicotinamide, allopurinol, and alpha-lipoic acid, alone and in combination to prevent DRG neuron oxidative stress and cell death. This combination of drugs is currently in clinical trial in type 1 diabetic patients. We demonstrate independent effects on oxidative stress and neuronal survival for the three drugs, and neuronal protection using the three drugs in combination. The data strengthen the rationale for the current clinical trial. In addition, we describe an effective tool for rapid preclinical testing of novel therapies against diabetic neuropathy.
Insights
This study shows that nicotinamide, allopurinol, and alpha-lipoic acid can protect nerve cells from oxidative stress and cell death in diabetes. This combination therapy is effective for diabetic neuropathy treatment.
Area of Science:
- Neuroscience
- Diabetology
- Pharmacology
Background:
- Oxidative stress is a key factor in diabetic nerve injury.
- Developing targeted therapies is crucial for managing diabetic neuropathy.
Purpose of the Study:
- To evaluate the efficacy of nicotinamide, allopurinol, and alpha-lipoic acid in preventing oxidative stress and cell death in diabetic neuropathy.
- To validate a high-throughput screening model for preclinical testing of novel therapies.
Main Methods:
- Utilized an in vitro model of glucose-treated dorsal root ganglion (DRG) neurons.
- Assessed free radical generation using fluorimetric probes for reactive oxygen species.
- Quantified cell death via the TUNEL assay in a 96-well plate format.
Main Results:
- Nicotinamide, allopurinol, and alpha-lipoic acid demonstrated independent protective effects against oxidative stress and neuronal death.
- The combination of these three drugs significantly enhanced neuronal protection.
- The study confirmed the drugs' efficacy in preventing DRG neuron oxidative stress and cell death.
Conclusions:
- The findings support the use of this drug combination in clinical trials for diabetic neuropathy.
- The established in vitro model provides an effective tool for rapid preclinical screening of potential diabetic neuropathy therapies.
